
Capital Genetics
AI Verified
Slovenia
Venture Capital
Slovenska cesta 54, Ljubljana, 1000, SI
2012
Criteria | Requirements | Match |
---|---|---|
Regions | Eastern Europe, Northern Europe, Southern Europe |
00
|
Countries |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Sector |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Impact Area |
00 00 00
|
|
Stage | Series A, Seed, Growth Stage |
00
|
Ticket size |
00 00 00
-
00 00 00
USD
|
00
|
Monetization model |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Product readiness |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Client types |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Min. revenue |
00 00 00
USD
|
00
|
Other |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
- |
Company description
Capital Genetics has established itself as a dynamic corporate finance advisory boutique serving the Central and Eastern European (CEE) and South-Eastern European (SEE) markets. The firm brings together a cohesive team of seasoned partners and professionals who collectively possess several decades of regional expertise. This boutique advisory practice has experienced rapid growth due to its deep understanding of local market dynamics and ability to navigate complex financial landscapes across emerging European economies.
The firm's comprehensive service platform addresses sophisticated financial challenges faced by businesses operating in the region. Their integrated solutions approach encompasses mergers and acquisitions advisory, capital raising, restructuring services, and strategic financial consulting tailored to the unique regulatory and economic environments of CEE and SEE countries. Capital Genetics has built a reputation for successfully executing cross-border transactions and providing nuanced market insights that larger international firms often lack in these developing markets.
What distinguishes Capital Genetics is their team's extensive network of relationships with local business leaders, financial institutions, and regulatory authorities throughout the region. This connectivity enables them to identify opportunities and facilitate transactions that might otherwise remain undiscovered. The firm typically engages with mid-market companies seeking growth capital, strategic partnerships, or exit strategies, as well as with international investors looking to establish or expand their presence in these high-potential markets.
Beyond transaction execution, Capital Genetics provides ongoing strategic guidance to help clients navigate post-deal integration challenges and capitalize on growth opportunities. Their sector expertise spans industries critical to the region's economic development, including technology, manufacturing, consumer goods, energy, and financial services. The firm maintains offices in key regional financial centers, allowing them to combine local market intelligence with sophisticated financial advisory capabilities typically associated with larger investment banks, creating a distinctive value proposition for clients operating in or expanding to the CEE and SEE regions.
Highlights
Ready to raise better?
Create your Free Account!
Frequently asked questions
Capital Genetics maintains its global headquarters in Slovenia, serving as the strategic center for its operations. The company's primary corporate offices are located at Slovenska cesta 54, Ljubljana, 1000, SI.
Capital Genetics focuses its investment activities on companies operating in the following stages: Series A, Seed, Growth Stage. Capital Genetics provides strategic capital and expertise to support promising businesses at these critical phases of development.
Capital Genetics maintains a strategic global investment presence, actively seeking opportunities across the following key regions: Eastern Europe, Northern Europe, Southern Europe.
Capital Genetics was established in 2012, marking the beginning of its journey as an investment firm.
Capital Genetics is the following type of investment firm: Venture Capital. The organization provides capital and strategic support to entrepreneurs and growing companies.